Adjuvant vinblastine plus bleomycin continuous infusion chemotherapy of testicular carcinomas following radical retroperitoneal dissection

S. Monfardini, G. Pizzocaro, E. Villa, S. Andreola

Research output: Contribution to journalArticle

Abstract

Fourteen previously untreated patients with testicular carcinoma metastatic to the retroperitoneal lymph nodes received adjuvant chemotherapy following orchiectomy and radical retroperitoneal dissection (RPLND). Two to three weeks from surgery, patients were administered vinblastine, 6 mg/m 2 on days 1 and 2, followed by continuous intravenous administration of bleomycin, 15 mg/m 2/day, for 5 successive days. This combination was repeated at 4-5 week intervals for 3 cycles. Median follow-up period after RPLND was 17 months (range 8-34). Three of 14 patients relapsed after 2, 6, and 10 months. In all these patients, extracapsular spread was present, while in 2 of them, more than 5 nodes of involvement had been demonstrated at RPLND. To critically evaluate the efficacy of adjuvant chemotherapy in testicular carcinomas, a detailed evaluation of prognostic factors in those series treated with RPLND alone should be performed.

Original languageEnglish
Pages (from-to)51-57
Number of pages7
JournalKanser
Volume9
Issue number2
Publication statusPublished - 1979

Fingerprint

Vinblastine
Bleomycin
Dissection
Carcinoma
Drug Therapy
Adjuvant Chemotherapy
Orchiectomy
Intravenous Administration
Lymph Nodes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Adjuvant vinblastine plus bleomycin continuous infusion chemotherapy of testicular carcinomas following radical retroperitoneal dissection. / Monfardini, S.; Pizzocaro, G.; Villa, E.; Andreola, S.

In: Kanser, Vol. 9, No. 2, 1979, p. 51-57.

Research output: Contribution to journalArticle

Monfardini, S. ; Pizzocaro, G. ; Villa, E. ; Andreola, S. / Adjuvant vinblastine plus bleomycin continuous infusion chemotherapy of testicular carcinomas following radical retroperitoneal dissection. In: Kanser. 1979 ; Vol. 9, No. 2. pp. 51-57.
@article{ae9258183b9e4eed9a3202e43e733955,
title = "Adjuvant vinblastine plus bleomycin continuous infusion chemotherapy of testicular carcinomas following radical retroperitoneal dissection",
abstract = "Fourteen previously untreated patients with testicular carcinoma metastatic to the retroperitoneal lymph nodes received adjuvant chemotherapy following orchiectomy and radical retroperitoneal dissection (RPLND). Two to three weeks from surgery, patients were administered vinblastine, 6 mg/m 2 on days 1 and 2, followed by continuous intravenous administration of bleomycin, 15 mg/m 2/day, for 5 successive days. This combination was repeated at 4-5 week intervals for 3 cycles. Median follow-up period after RPLND was 17 months (range 8-34). Three of 14 patients relapsed after 2, 6, and 10 months. In all these patients, extracapsular spread was present, while in 2 of them, more than 5 nodes of involvement had been demonstrated at RPLND. To critically evaluate the efficacy of adjuvant chemotherapy in testicular carcinomas, a detailed evaluation of prognostic factors in those series treated with RPLND alone should be performed.",
author = "S. Monfardini and G. Pizzocaro and E. Villa and S. Andreola",
year = "1979",
language = "English",
volume = "9",
pages = "51--57",
journal = "Kanser",
issn = "0377-9750",
publisher = "Turkish Association for Cancer Research and Control",
number = "2",

}

TY - JOUR

T1 - Adjuvant vinblastine plus bleomycin continuous infusion chemotherapy of testicular carcinomas following radical retroperitoneal dissection

AU - Monfardini, S.

AU - Pizzocaro, G.

AU - Villa, E.

AU - Andreola, S.

PY - 1979

Y1 - 1979

N2 - Fourteen previously untreated patients with testicular carcinoma metastatic to the retroperitoneal lymph nodes received adjuvant chemotherapy following orchiectomy and radical retroperitoneal dissection (RPLND). Two to three weeks from surgery, patients were administered vinblastine, 6 mg/m 2 on days 1 and 2, followed by continuous intravenous administration of bleomycin, 15 mg/m 2/day, for 5 successive days. This combination was repeated at 4-5 week intervals for 3 cycles. Median follow-up period after RPLND was 17 months (range 8-34). Three of 14 patients relapsed after 2, 6, and 10 months. In all these patients, extracapsular spread was present, while in 2 of them, more than 5 nodes of involvement had been demonstrated at RPLND. To critically evaluate the efficacy of adjuvant chemotherapy in testicular carcinomas, a detailed evaluation of prognostic factors in those series treated with RPLND alone should be performed.

AB - Fourteen previously untreated patients with testicular carcinoma metastatic to the retroperitoneal lymph nodes received adjuvant chemotherapy following orchiectomy and radical retroperitoneal dissection (RPLND). Two to three weeks from surgery, patients were administered vinblastine, 6 mg/m 2 on days 1 and 2, followed by continuous intravenous administration of bleomycin, 15 mg/m 2/day, for 5 successive days. This combination was repeated at 4-5 week intervals for 3 cycles. Median follow-up period after RPLND was 17 months (range 8-34). Three of 14 patients relapsed after 2, 6, and 10 months. In all these patients, extracapsular spread was present, while in 2 of them, more than 5 nodes of involvement had been demonstrated at RPLND. To critically evaluate the efficacy of adjuvant chemotherapy in testicular carcinomas, a detailed evaluation of prognostic factors in those series treated with RPLND alone should be performed.

UR - http://www.scopus.com/inward/record.url?scp=0018554912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018554912&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0018554912

VL - 9

SP - 51

EP - 57

JO - Kanser

JF - Kanser

SN - 0377-9750

IS - 2

ER -